Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Turning Point

Petalfast Partners With Turning Point Brands To Expand Distribution Of Rolling Paper Brand Zig-Zag

Petalfast Inc., a full-spectrum marketing and sales agency for the cannabis industry, entered into partnership with Turning Point Brands, Inc. (NYSE: TPB), to drive distribution expansion of their iconic rolling paper brand, Zig-Zag

Benzinga

Stigma a hurdle to treatment for addiction

Destigmatising addiction and acknowledging its relationship with trauma would help sufferers get help sooner, says an expert and a recovering heavy drug user.

AAP

IBD Stock Of The Day: Bristol Myers Eyes Breakout After $4.1 Billion Buyout

Bristol Myers Squibb is the IBD Stock Of The Day as BMY stock bounds off its 50-day line, presenting investors with an early entry.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Upgrades

Benzinga

Merger Arbitrage Mondays – Bristol Myers (BMY) Acquires Third Point Therapeutics (TPTX)

Another week and another deal with big pharma buying out a development stage oncology company. Given the real synergies to be had through young companies partnering with big pharma to leverage their manufacturing expertise and distribution networks, regulators have allowed most of them to go through and they tend to…

Benzinga

Biotech buyout: San Diego's Turning Point Therapeutics sells to Bristol Myers Squibb for $4.1 billion

Bristol Myers Squibb has inked a deal to buy San Diego's Turning Point Therapeutics for $4.1 billion in cash, strengthening the pharmaceutical giant's presence in precision cancer treatments.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead?

Turning Point Therapeutics snagged a $4.1 billion offer from Bristol Myers Squibb on Friday, and TPTX stock more than doubled.

Investors Business Daily

Expert Ratings for Turning Point

Over the past 3 months, 4 analysts have published their opinion on Turning Point (NASDAQ:TPTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Upgrades

Benzinga

Focus V Nabs Turning Point Canada As Exclusive Distributor, Cannabis Heating Devices Will Benefit

Focus V line of product offerings is now available in Canada, exclusively distributed by Turning Point Brands (NYSE: TPB).

Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Benzinga

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Benzinga

'Caring' man, 21, fell from viaduct despite desperate attempts of police officers, inquest hears

'I would like to commend PC Oliver for his actions that day. It’s clear that he’s a very caring officer who tried his best to help Elliot'

Manchester Evening News

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Charlie Kirk’s plans for ‘America First’ school in doubt as contractor pulls out

Turning Point USA online learning academy claimed students were being taught a ‘false narrative about America’

Reason

David Lat on the Crystal Clanton Matter

As usual, Lat puts it very well in his "Original Jurisdiction" Substack newsletter (I've paid for a subscription, and highly recommend it): Last fall, [Chief Judge Pryor] was widely criticized for hiring an allegedly racist law clerk—specifically, Crystal Clanton, now a 3L at George Mason aka Scalia Law. According to…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.